Eike Burandt

Author PubWeight™ 7.73^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.	J Natl Cancer Inst	2013	2.28
2	Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.	Clin Cancer Res	2010	1.28
3	Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.	Cancer	2012	1.00
4	Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis.	Hepatology	2013	0.93
5	MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.	Anticancer Res	2014	0.81
6	MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.	Histopathology	2013	0.78
7	Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.	World J Urol	2011	0.77
8	HER2 amplification in squamous cell carcinomas of the vulva.	Histopathology	2013	0.75
9	Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.	Oncotarget	2017	0.75